Diabetic retinopathy 3: surgical treatment
Authors:
Jana Štefaničková; Vladimír Krásnik
Authors‘ workplace:
Klinika oftalmológie LF UK a UN Bratislava, prednosta doc. MUDr. Vladimír Krásnik, PhD.
Published in:
Forum Diab 2013; 2(3): 170-175
Category:
Main Theme: Review
Overview
Millions of people around the world each year face vision loss related to diabetes. Diabetic retinopathy is the most common cause of visual impairment in the working age population. In some cases only surgery is able to save vision. Typical indications for vitrectomy are vitreous hemorrhage, tractional retinal detachment, combined tractional rhegmatogenous retinal detachment and traction macular edema. Vitreoretinal surgeons in these days are able to manage severe proliferative diabetic retinopathy. The functional results depend on the degree of retinal ischemia, especially in macula. Sometimes it may be disappointing even in anatomically successfully operated eyes. The decision for surgery in diabetic patients always requires a weighing of risks and benefits of surgery.
Key words:
diabetic macular edema – diabetic retinopathy – pars plana vitrectomy
Sources
1. Brancato R, Lumbroso, B. Guide to optical coherence tomography interpretation. I.N.C.Innovation – News – Communication: Roma 1994. ISBN 978–888–6193–4-12.
2. Colagross CT, Vail R et al. Diabetic vitrectomy: risks, prognosis, future trends. Curr Opin Opthalmol 2006; 17(3): 281–285.
3. Eckartd C. Transconjuctival sutureless 23-guage vitrectomy. Retina 2005; 25(2): 208–211.
4. Fišer I, Handlová R, Bedrich P et al. Peeling MLI v léčbe chorob vitreomakulárního rozhraní. In: Sborník abstrakt (8. Vejdovského olomoucký vědecký den, Olomouc, ČR, 24.3. 2007): 38–42.
5. Fišer I. Vitrektomie. In: Sosna T, Bouček P, Fišer I. Diabetická retinopatie: diagnostika, prevence a léčba. J. Cendelín: Praha 2001: 209–229.
6. Flaxel CJ, Edwards AR, Aiello LP et al. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina 2010; 30(9): 1488–1495.
7. Fong DS, Aiello LP, Ferris FL 3rd et al. Diabetic Retinopathy. Diabetes Care 2004; 27(10): 2540–2553.
8. Fong DS, Segal PP, Myers F et al. Subretinal fibrosis in diabetic macular edema. EDTRS report 23. Arch Ophthalmol 1997; 115(7): 873–877.
9. Fuji GY, de Juan E jr, Humayun MS et al. A new 25-guage instrument system for transconjuctival sutureless vitrectomy surgery. Ophthalmology 2002; 109(10): 1807–1813.
10. Gandorfer A, Messmer E, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000; 20(2): 123–133.
11. Gandorfer A, Haritoglu C, Kampik A et al. Ultrastructure of the vitreoretinal interface following removal of the internal limiting membrane using indocyanine green. Curr Eye Res 2004; 29(4–5): 319–320.
12. Helbig H. Surgery for diabetic retinopathy. Ophthalmologica 2007; 221(2): 103–111.
13. Hikichi T, Fujio N, Akiba Y et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997; 104(3): 473–478.
14. Lang, GE. Optical coherence tomography findings in diabetic retinopathy. Dev Ophthalmol 2007; 39: 31–47.
15. La Heij EC, Hendrikse F, Kessels AG et al. Vitrectomy results in diabetic macular edema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 2001; 239(4): 264–270.
16. Lewis H, Abrams GW, Blumenkraz MSet al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloid traction. Ophthalmology 1992; 99(5): 753–759.
17. Machemer R, Norton EDW. A new concept for vitreous surgery. 3. Indications and results. Am J Ophtrhalmol 1972; 74(6): 1034–1056.
18. Massin P, Duguid G, Erginay A et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 2003; 135(2): 169–177.
19. Matsunaga N, Ozeki H, Hirabayashi Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 2005; 25(3): 311–316.
20. Morris R, Witherspoon CD, Kuhn F et al. Forceps removal of the retina internal limiting membrane in surgery for macular hole and macular pucker. American Academy of Ophthalmology, Annual Meeting, Dallas, Texas, 22- 25 október, 2000.
21. Nasrallah FP, Jalkh AE, van Coppenrolle F et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988; 95(10): 1335–1339.
22. Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 2002; 134(2): 214–219.
23. Pendergast SD, Hassan TS, Williams GA et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Opthalmol 2000; 130(2): 178–186.
24. Rintelen F. Albrecht von Graefe, seine Persönlichkeit, seine Zeit” [Albrecht von Graefe, his personality and his times]. Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie 1971; 181 (2): 79–93.
25. Quiroz-Mercado H, Alfaro III DV, Ligget PE et al. Macular surgery. 2nd. ed. Lippincott Williams &Wilkins: Philadelphia 2011. ISBN 978-078-1797-1-53.
26. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996; 122(2): 258–260.
27. The Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial. Diabetic Retinopathy Vitrectomy Study Report Number 3. Ophthalmology 1988; 95(10): 1307–1320.
28. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: The role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001; 132(3): 369–377.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
![Issue 3](https://www.forumdiabetologicum.sk/media/cache/resolve/journal_issue/media/image_pdf/8e6ef7e34cec8038ec37ed7db19d09ce.jpeg)
2013 Issue 3
Most read in this issue
- Diabetic retinopathy 3: surgical treatment
- Diabetes mellitus and glaucoma
- Anti-VEGF treatment of diabetic 1. type: case report
- Why is the treatment of diabetes important a how can be achieved?